Company / Shares Outstanding
Vaxcyte, Inc. Shares Outstanding History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
136.1M
FY2025
5-year range
51.9M / 136.1M
FY2021-FY2025
Trend
+11.6%
vs FY2024
Sector context
#77 of 212
Health Care
What the data says
At 136089506.00, Vaxcyte, Inc.'s shares outstanding ranks #136 of 212 in the Health Care sector. Shares Outstanding has increased for 7 consecutive years, from 3629896.00 in FY2018 to 136089506.00 in FY2025.
Based on SEC 10-K filings.
136089506.00 in FY2025 with a 5-year CAGR of +35.7%.
Increased from 97157690.00 to 136089506.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +28.0%
- 5-Year CAGR
- +35.7%
- 10-Year CAGR
- -
Sector benchmark
#136 of 212 in Health CareTop 64% of 212This company 136.1M Sector average 306.7M
▼
-55.6% below sector average
Key checks
Key Insights
- Vaxcyte, Inc.'s shares outstanding has grown for 7 consecutive years.
- In FY2025, shares outstanding increased 11.6% year-over-year.
- Ranks #77 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.94 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 136.1M | +11.6% |
| FY2024 | 122.0M | +25.6% |
| FY2023 | 97.2M | +49.8% |
| FY2022 | 64.9M | +25.0% |
| FY2021 | 51.9M | +75.7% |
| FY2020 | 29.5M | +678.5% |
| FY2019 | 3.8M | +4.6% |
| FY2018 | 3.6M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026